Early access
Sign in
Taking people in Hong KongNo phase

Freezing Ovarian Tissue to Preserve Fertility in Young Women With Cancer

Tests freezing and later returning ovarian tissue to females with cancer, to help preserve fertility.

Key facts

Who runs it
Chinese University of Hong Kong
Where
Hong Kong, Hong KongSee the site
Trial code
Registry title
Ovarian Tissue Cryopreservation and Subsequent Auto-Transplantation for Female Cancer Patients
Status
Recruiting
People taking part
100 people, planned
Started
1 Aug 2023
Expected to end
30 Dec 2043
Type of study
Interventional
Treatments tested
  • Ovarian tissue freezing and subsequent auto-transplantation after thawing
Record updated
7 January 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for girls and women up to 35 years old with cancer, or who face treatment that could harm their fertility, to freeze ovarian tissue.

Age
From 1 Month to 35 Years (the criteria say 0-35 years old).
Sex
Female only.
Disease stage
Cancer such as leukaemia, lymphoma, bone tumours, neurological neoplasms or sarcoma. Also any illness or treatment that may cause irreversible damage to fertility.
Earlier treatment
Not stated. Patients must be going to have treatment that may damage their ovaries or fertility.

Main reasons for not taking part

  • No anticipated cancer therapies
  • Pregnant patients
  • Children with one ovary
  • Children at high risk for complications during surgery
  • Patients unable to give consent or assent

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Patients aged from 0-35 years old and diagnosed with cancer e.g., leukaemia, myeloproliferative or myelodysplastic diseases, lymphoma, bone tumours, neurological neoplasms and sarcoma, Paediatric bone marrow transplant patients
  • Patients with any illness or who will undergo any type of treatment that may cause irreversible damage to their fertility, such as extensive abdominal surgery, high toxicity medication and treatments
  • Patients suffering from hormone-sensitive malignancies who will undergo medical treatment, such as radiotherapy and chemotherapy that is liable to damage their ovaries and deter them from conception in the future

Who cannot take part

  • Patients with no anticipated oncologic therapies
  • Patients unable to provide consent/assent (i.e. significant psychiatric problems/cognitive delay)
  • Patients who are pregnant
  • Children with one ovary
  • Children deemed high risk for perioperative complications

Where in Hong Kong

  • Prince of Wales HospitalHong Kong, Hong KongContact: Jacqueline Pui Wah Chung, MBBSTaking people

About the trial

What the trial wants to find out

Ovarian Tissue Cryopreservation will be provided to cancer patients to allow them to have their fertility preserved.

The group in the trial

  • Ovarian tissue freezing and subsequent auto-transplantation after thawingTreatment being tested

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Ovarian Tissue Cryopreservation and Subsequent Auto-Transplantation for Female Cancer Patients
Plain-language title
Freezing Ovarian Tissue to Preserve Fertility in Young Women With CancerGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
7 January 2026